Latest Capital Raises News

TechGen Metals has reported a standout 20m @ 1.14% copper intercept at Mt Boggola and secured key drilling approvals at Blue Devil, setting the stage for multiple exploration campaigns in 2026.

Hot Chili Limited secured A$40 million in a private placement to fast-track development of its Costa Fuego copper-gold project in Chile, buoyed by significant high-grade drill results extending the La Verde discovery footprint.

Reach Resources has boosted its Blue Heaven gold resource by roughly 30% to 80,000 ounces, supported by strong metallurgical results and a newly granted mining lease, while progressing a $3.15 million rights issue to fund further exploration and development.

NeuroScientific Biopharmaceuticals reported positive clinical responses in its StemSmart™ Special Access Program for fistulising Crohn’s disease and has initiated manufacturing technology transfer to support Phase 2 trials planned for late 2026.

Recharge Metals has completed the acquisition of the Sunset Well Gold Project near Leonora, WA, backed by a $6 million capital raise. The project hosts a 94,500-ounce inferred gold resource with significant exploration upside.

Algorae Pharmaceuticals strengthened its balance sheet with $5.47 million cash reserves and broadened its commercial footprint through new licensing deals and AI-driven drug validation.

BlinkLab has completed onboarding all clinical sites for its pivotal FDA autism trial, enrolled the first participant, and launched a nationwide autism screening program in Morocco. A recent A$17.7 million capital raise will fund further trials and expansion into ADHD diagnostics.

One Click Group delivered a remarkable 1000% increase in new users and a 64% reduction in acquisition costs in Q1 2026, setting the stage for strong revenue growth ahead of tax season.

Dateline Resources is poised to release its Colosseum Gold Project Bankable Feasibility Study imminently, while expanding rare earth exploration at its new Music Valley project and bolstering its balance sheet with a $50 million placement.

AdAlta has launched its East-to-West cellular immunotherapy strategy through a co-development deal for CAR-T therapy BZDS1901, showing promising complete tumour clearance in mesothelioma patients and transferring manufacturing to Australia to boost scalability.

Livium Ltd boosted battery recycling revenue and secured a new centralised hub to expand capacity, while advancing rare earth and solar panel recycling technologies. Strategic funding for its lithium cathode plant remains under review.

Medallion Metals has greenlit development at Ravensthorpe following a $50 million loan and environmental approval, while integrating Forrestania assets to underpin a multi-source gold strategy.